|
Market Closed -
Nasdaq
16:00:00 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 44.00 USD | -1.46% |
|
+0.43% | -44.38% |
| 09-10 | Ionis Pharmaceuticals, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-10-2026 08:45 AM | |
| 09-09 | BofA Adjusts Price Target on Ionis Pharmaceuticals to $91 From $93 | MT |
Company Valuation: Ionis Pharmaceuticals, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,297 | 5,365 | 7,258 | 5,520 | 12,814 | 7,312 | - | - |
| Change | - | 24.86% | 35.28% | -23.95% | 132.13% | -42.94% | - | - |
| Enterprise Value (EV) 1 | 4,649 | 4,561 | 6,157 | 4,468 | 11,136 | 7,209 | 7,380 | 7,403 |
| Change | - | -1.89% | 34.98% | -27.43% | 149.25% | -35.26% | 2.38% | 0.31% |
| P/E | -152x | -19.9x | -19.8x | -11.5x | -33.2x | -12.3x | -22.6x | 215x |
| PBR | 5.57x | 9.37x | 18.9x | 9.38x | 26.4x | 400x | -59.5x | 43.1x |
| PEG | - | -0x | -0.6x | -0.6x | 1.5x | -0.2x | 0.5x | -2x |
| Capitalization / Revenue | 5.3x | 9.14x | 9.21x | 7.83x | 13.6x | 7.95x | 5.36x | 3.84x |
| EV / Revenue | 5.74x | 7.77x | 7.81x | 6.34x | 11.8x | 7.84x | 5.41x | 3.89x |
| EV / EBITDA | 35.6x | -11.5x | -18x | -9.6x | -30x | -12.6x | -23.9x | 98.7x |
| EV / EBIT | -155x | -11.1x | -17.4x | -9.41x | -29.2x | -12.4x | -21.1x | 258x |
| EV / FCF | 247x | -15.7x | -18.6x | -8.18x | -34.8x | -13.5x | -22x | -93.7x |
| FCF Yield | 0.41% | -6.36% | -5.38% | -12.2% | -2.87% | -7.39% | -4.55% | -1.07% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.2 | -1.9 | -2.56 | -3.04 | -2.38 | -3.584 | -1.951 | 0.205 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 810 | 587 | 788 | 705 | 944 | 919.5 | 1,365 | 1,905 |
| EBITDA 1 | 130.5 | -395.9 | -342.7 | -465.4 | -371.7 | -573 | -308.8 | 75.03 |
| EBIT 1 | -30 | -411 | -353 | -475 | -382 | -581.3 | -349.2 | 28.74 |
| Net income 1 | -29 | -270 | -366 | -454 | -381 | -576.2 | -330.2 | 24.6 |
| Net Debt 1 | 352 | -804.2 | -1,102 | -1,052 | -1,678 | -103 | 68.31 | 90.9 |
| Reference price 2 | 30.43 | 37.77 | 50.59 | 34.96 | 79.11 | 44.00 | 44.00 | 44.00 |
| Nbr of stocks (in thousands) | 141,210 | 142,050 | 143,472 | 157,897 | 161,974 | 166,184 | - | - |
| Announcement Date | 2/24/22 | 2/22/23 | 2/21/24 | 2/19/25 | 2/25/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -12.28x | 7.84x | -12.58x | -.--% | 7.31B | |
| 21.73x | 7.77x | 15.61x | 1.37% | 74.41B | |
| 30.79x | 8.87x | 27.62x | 0.04% | 59.26B | |
| 32.79x | 5.89x | 17.64x | 0.99% | 47.14B | |
| 33.58x | 3.26x | 14.07x | -.--% | 42.91B | |
| -21.23x | 229.92x | -22.88x | -.--% | 44.13B | |
| 46.86x | 5.42x | 29.73x | -.--% | 40.79B | |
| 27.79x | 7.97x | 20.59x | 0.41% | 30.77B | |
| 33.94x | 7.26x | 18.84x | -.--% | 29.31B | |
| -66.62x | 12.77x | -65.09x | -.--% | 23.71B | |
| Average | 12.74x | 29.70x | 4.35x | 0.28% | 39.98B | |
| Weighted average by Cap. | 18.97x | 31.79x | 9.97x | 0.41% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IONS Stock
- Valuation Ionis Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
